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ABSTRACT
Calcium phosphate is deposited in many diseases, but the molecular basis of mineralization remains largely unknown. Biomineralizied 
calcifications that are formed by calcium deposits are also detected in breast mammograms. Some of the detected microcalcifications are 
thought to be related with malignancy. Taken together, calcifying nanoparticles (CNP) may be thought as a source of malign calcifications 
in breast cancers. The aim of the study is to research the presence of CNP in breast tumor tissue.  With this aim, the presence of CNP was 
investigated by culturing 16 patients’ breast tumor tissue and from 2 pathologic tissues with transmission electron microscopy (TEM) and 
scanning electron microscopy (SEM). Their growth was monitored by optical density (OD) at a wavelength of 650 nm. CNP couldn’t be 
found in the analysed tissues. The presence of CNP in the breast tumor tissue was researched for the first time. We could not find CNP in 
the breast tumor tissue, but we think this research will open a new field of study for researchers. 
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ÖZET
Meme Tümöründe Kalsifiye Edici Nanopartiküllerin Varlığına Dair Bir Ön İnceleme
Kalsiyum fosfat depolanması pek çok hastalıkta görülür, fakat mineralizasyonun moleküler nedeni büyük oranda bilinmemektedir. Kalsiyum 
depolanmasıyla oluşan biyomineral kalsifikasyonlar mamogramla saptanmaktadır. Saptanan mikrokalsifikasyonların bazılarının maligniteyle 
ilişkili olabileceği düşünülmektedir. Tüm bu bilgiler göz önüne alındığında, kalsifiye edici nanopartiküller (CNP) malign kalsifikasyonların 
nedeni olarak düşünülebilir. Bu çalışmanın amacı, meme tümör dokusunda CNP varlığını araştırmaktır. Bu amaçla, CNP varlığı 16 hastanın 
meme tümör dokusunun kültürü sonrası ve 2 patolojik dokunun geçirimli ve taramalı elektron mikroskopları (TEM ve SEM) ile incelenmesi 
ve 650 nm’de optik densitenin ölçülmesi ile araştırılmıştır. Analiz edilen dokularda CNP saptanamamıştır. Bu çalışmayla, CNP varlığı ilk defa 
meme tümör dokusunda araştırılmıştır. Meme tümör dokusunda CNP bulunamamakla birlikte bu çalışmanın araştırmacılara yeni araştırma 
alanları açacağı düşünülmektedir.
Anahtar Kelimeler: Meme tümörü, Kalsifikasyon, Kalsifiye edici nanopartiküller, Taramalı elektron mikroskobu, Geçirmeli elektron mik-
roskobu
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INTRODUCTION
The formation of organized inorganic crystalline 
structures within macromolecular extracellular matri-
ces is referred to as “biomineralization”. Mammalian 
bone and dental enamel are examples of biominerali-
zation. The formation mechanisms of mineralization 
remain speculative and largely unknown.1 Calcifica-
tion of soft tissues, termed “pathologic calcification” 
is a common process in a wide variety of diseases2 like 
aortic valve stenosis, atherosclerosis and psammoma 
bodies in ovarian cancer.3-6 Breast calcifications are 
deposits of calcium that can be seen on breast mam-
mograms.7 One of the most important roles of cal-
cification detection in mammography is the identifi-
cation of malignancy. The other important role is in 
the follow up of breast cancer patients having breast 
conservation therapy as calcifications have been de-
tected in 29-80% of recurrences. Morover, there is 
an increased risk of malignancy associated with an 
increased number of calcifications.2 Calcifications 
associated with benign conditions are usually larger, 
fewer in number, widely dispersed, and round.7
There are two forms of microcalcification in breast 
disease: Type I and Type II. Type I is composed of 
calcium oxalate and these oxalate calcifications are 
generally associated with proliferating but noninva-
sive diseases of the breast. On the other hand, Type II 
consists predominantly of calcium phosphate. Calci-
um phosphate in the crystalline form of hydroxyapa-
tite is usually correlated to invasive malign tumors. 
The mechanism that causes deposition of the bone-
specific mineral hydroxyapatite has not yet been il-
luminated.7
Calcifying nanoparticles (CNP) (nanobacteria, na-
nons, nanobes, nanobacteria-like particles) were dis-
covered as cell culture contaminants by Kajander et al 
in bovine and human blood in the last decade of 20th 
century. The name is derived from the very small size 
of these nanoparticles, which varies from 50 nanom-
eters to 500 nanometers. The defining characteristics 
of CNP is their outer envelope composed of calcium 
phosphate that presents on transmission electron 
microscope images as an electron-dense shell sur-
rounding a translucent central core. They produce 
carbonate apatite on their cell envelope from soluble 
calcium and phosphorus at physiologic concentra-
tions and conditions. However, there is still a big de-
bate about whether these self-mineralizing particles 
are bacteria or inorganic substances with the capacity 
for extensive crystallization.8-10
Discovery of CNP initiated further studies and have 
now been implicated in a wide array of human dis-
eases associated with calcifications like: kidney stone 
formation1, prostatitis11, psammoma bodies in ovarian 
cancer6,12, Randall’s plaque13, testicular microlithi-
asis14, calcification in placenta15, calcific aortic valve 
stenosis4,16, atherosclerotic plaques5, and dental pulp 
stones.17
Taken together, since microcalcifications are one of 
the most common abnormalities detected on screen-
ing mammography for breast cancer7 and CNP has 
been shown to contribute to different benign and 
malign calcifications11-16, CNP may also contribute 
to malign calcifications in breast cancer. Thus, in the 
light of these investigations and results, this study fo-
cuses on researching the presence of CNP in calcified 
breast tumor tissues for the first time.
MATERIALS AND METHODS
Clinical sample collection
All enrolled patients agreed to sign written consent 
forms and the study was approved by Kırıkkale Uni-
versity Ethics Board. Sixteen women, aged 43-74 
(median 57), all having breast carcinoma (7; infiltra-
tive ductal, 5; invazive ductal, 1; mucinose, 1; meta-
plastic, 1; mix type-infiltrative ductal+infiltrative lob-
uler-, and 1; inflamatuar carcinoma) were accepted 
for this study. In addition to 16 patients’ tumor tis-
sues, 2 paraffin embedded breast tumor tissues are 
included in this study.
Cultivation of calcifying nanoparticles
Before culturing tumor tissues, we prepared cultures 
with DMEM supplemented with 10% fetal bovine 
serum (FBS) (filtered through 0.22 µm filters) to 
observe CNP under mammalian cell culture condi-
tions (370C, 5% CO2, 95% air). These were our posi-
tive control cultures. The incubation period was 6-8 
weeks.
The breast tumor tissues were divided into two parts: 
one of which was kept at 40C for direct analysis with-
out culturing and the other part was crushed in a ster-
ile glass petri by sterile surgical blades under laminair 
flow. It was demineralized by adding 1 M HCl, which 
was subsequently neutralizied with 1 M NaOH. The 
resultant was filtrated with a 0.22 µm membrane fil-
ter and cultured in DMEM supplemented with 10% 
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gamma-irradiated (γ)  and 0.22 µm membrane filtrat-
ed FBS at 370C, under 5% CO2 atmosphere.16 Also, 
cultures without tumor tissue cultured under the same 
conditions were used as the negative controls. After 
6-8 weeks of incubation, a culture scraping was ex-
ecuted in each flask, then centrifuged at 5000 x g for 
45 minutes and pellets were obtained.
Transmission electron microscopy (TEM)
PBS washed pellets were fixed by immersion in 2.5% 
gluteraldehyde in 0.1M phosphate buffer (pH 7.4) at 
room temperature for 3 hrs and post – fixed in 1% 
phosphate buffered osmium tetroxide for 2 hrs. Sam-
ples were dehydrated by being passed through the 
graded ethanol series and embedded in Araldite CY-
212. Ultra thin sections were contrast stained with 
uranyl acetate and lead citrate and examined using the 
Leo 906 E (80 kV) (Oberkohen-Germany) transmis-
sion electron microscope.16,18
For preparing slides from pathological samples which 
were previously processed for standard histological 
examination, paraffin blocks were placed in 100% 
xylene for 1-2 hrs until no evidence of paraffin re-
mains then rehydration in ethanols was performed. 
After incubation in 1% osmium tetroxide for 1 hr, 
they were dehydrated and embeded in Araldite CY 
212 as for routine TEM sample preparation.19
Also, breast tumor tissues of 16 patients that were 
kept at 40C, were screened by direct x-ray to see cal-
cificated areas. From 7 patients’ calcificated breast tu-
mor tissue areas, slides were prepared to be observed 
under TEM.
Scanning electron microscopy (SEM)
Only positive control cultures were screened by 
SEM. Pellets were washed with PBS then subcultured 
in serum-free RPMI-1640 on glass cover slips for 24 
hrs. The glass cover slips were washed with PBS and 
fixed with 2% gluteraldehyde for 30 min at room tem-
perature. Fixed samples were dehydrated with abso-
lute alcohol; dried in a critical point dryer and layered 
with gold followed by examination in SEM.
Figure 1. Scanning electron micrograph of calcifying nano-
particles.
Figure 2. Transmission electron micgraph of calcifying nano 
particles (Original magnification is 100.000X).
Figure 3. Transmission electron micgraph of calcifying nano-
particles (Original magnification is 129.300X)
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Microbiologic tests
To be sure about the non-existance of classical mi-
crobes in our CNP cultures, subcultures were per-
formed on 200 µl pellets in a mycoplasma liquid 
medium, sheep-blood agar and eosin methylen blue 
(EMB) agar both in aerobic and anaerobic conditions. 
Morover, Gram and Giemsa stainings were done.
Spectrophotometry
Maximum absorbances of pellets were measured by 
spectrophotometer.
RESULTS
Calcifying nanoparticle culture results, imag-
ing by TEM and SEM: After 8 weeks of culture, 
we could observe CNP like particules in our positive 
control cultures including DMEM supplemented with 
10% FBS both with SEM and TEM. SEM of the posi-
tive control culture revealed coccobacillary particles 
with a diameter ranging between 100 and 200 nm. 
The particles were prokaryotic in shape. (Figure 1). 
TEM also showed coccoid structures wrapped by a 
high electron-dense, thick outer shell (Figure 2 and 
3). These morphologic and distinctive features are 
the same as those of CNP described in previous stud-
ies.1,18,20 But neither in the cultures with breast tumor 
tissues nor in our negative control cultures could we 
observe CNP. 
TEM of pathologic tissue and calcified area re-
sults: From 2 pathologic breast tumor tissues and 
7 patients’ breast tumor tissues we tried to sign the 
calcified areas and tried to prepare slides for TEM 
only from these areas. CNP could not be imaged from 
these samples.
Microbiologic test results: A subculture of pellets 
on sheep blood agar, mycoplasma medium and EMB 
agar resulted without growing. Also, they couldn’t be 
dyed by Gram and Giemsa.
Spectrophotometric results: Maximum absorbance 
of breast tumor tissue pellets was 550-560 nm. 
DISCUSSION
CNP appear as self-propagating calcifying macromo-
lecular complexes found in bovine and human blood 
and blood products. There are still discussions about 
their nature, as living or non-living and it is certain 
that the discussions will continue until their genome 
can be accurately sequenced. Whether they are phys-
icochemical phenomenon or bacteria, they exist and 
cause diseases.10 The disease-causing mechanisms of 
CNP include the known effects of calcium on blood 
vessels, blood coagulation and thrombus formation; 
elevation of intracellular [Ca2+] levels and its conse-
quences. They grow better in the presence of other 
bacteria and this could change the normal flora and 
promote bacterial infection. CNP adhere to foreign 
objects, such as implants, and could result in bio-
film formation later attracting bacteria, leading to a 
chronic infectious problem that is often untreatable 
with antibiotics.21 
Guneslioglu, et al.3 and Altundag, et al.7 hypohesized 
a possible association between breast implant capsule 
contracture, malignant calcifications in breast cancer 
and CNP. Breast calcification is an important feature 
in the radiological assessment of breast lesions. Good 
understanding of the morphologic features and the 
mechanism of calcifications is crucial for health care 
professionals involved in breast care. When we take 
different calcification mechanisms into consideration, 
pathologic calcification can be classified as dystropfic 
and metastatic calcification. Dystropfic calcification 
may be intra- or- extracellular. While the initiation in 
extracellular sites begins at membrane bound vesi-
cles derived from degenerating cells; the initiation in 
intracellular sites begins in the mitochondria of the 
dead or dying cells. Calcifications detected in the 
breast is probably derived from dystropfic calcifica-
tion, not from metastatic one.2 There are two types 
of calcification molecules in breast tissue. One is 
calcium oxalate, which is crystalline and is present 
mostly in benign lesions. The other is non crystalline, 
which is a form of calcium phosphate and is associ-
ated with malign lesions.22 Osteopontin also appears 
to be a crucial mediator involved in the process of 
calcification. This mediator was found in the histio-
cytes around the lesional epithelial breast tissue, but 
at much lower level in tumor cells. In the scenario 
of high grade tumor, osteopontin expression may 
represent part of inflammatory response to cellular 
damage. In addition to construction mechanism of 
microcalcifications and the particles they include, the 
density, mass and number of calcifications are very 
important in the prognosis of breast lesions.2 For 
these reasons, in this study we planned to investigate 
the presence of CNP in calcified breast tumor tissues. 
Ciftcioglu, et al.23 found that CNP were best detect-
ed after cultivation. So, we prepared three types of 
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culture: One type was a positive control including 
DMEM with 10% FBS. This cultures’ aim was to cul-
ture and image CNP. These bacteria like particles can 
not grow and reproduce under common conditions 
for microbial culture, but need media for mammalian 
cell culture such as Roswell Park Memorial Institute 
(RPMI) 1640 medium or Dulbecco modified eagle 
medium to grow (DMEM).10,11 FBS was used as a 
supplement and source of CNP. The second type was 
the negative control cultures including DMEM with 
10% γ FBS. If FBS was added into the culture medi-
um directly, it gives false positive results. Fortunately, 
the destructive effects of γ ray irradiation on FBS can 
effectively eliminate powerful inhibitors of apatite 
crystal formation.24 So, we used γ FBS to avoid false 
positive results and did not expecting to observe CNP 
in these cultures as in the previous studies.1,24,25 The 
last culture was the same with our negative cultures, 
but we added our demineralized, neutralized and 0.22 
µm pore filtered breast tumor tissues to these cultures. 
Morover, FBS and γ FBS were both filtered before 
cultivation to prevent contamination by other bacte-
ria or fungi. It has also been shown that, nucleation 
capacity could be lost after 0.1 or o.05 µm membrane 
filtration.25 After 8 weeks of culture, we were able to 
manage to image CNP only in our positive controls, 
but not in the cultures of breast tumor tissues. Also, 
spectrophotometric measurements would indicate the 
presence of CNP if we measured OD650, but our re-
sults were OD550-OD560. This result made us think 
about the amount of calcification of our tissues. To 
be sure about imaging calcified breast tumor areas, 
we screened 16 patients breast tumor tissue that we 
were keeping at 40C by direct x-ray. For seven of the 
16 tissues, we were able to check off calcified areas 
and tried to prepare slides for TEM from these calci-
fied areas. Morover, we again prepared 2 slides for 
TEM from paraffin embedded calcified brest tumor 
tissues. But with the same result as our previous one, 
we could not observe CNP by TEM in these samples. 
Several methods are being used to detect CNP, like 
bacterioscopic, bacteriological, serological, genomic 
or proteomic methods, although some of these are 
still questinable.10 However, TEM is still a powerful 
tool for detecting and studying CNP.9 If we are able to 
see CNP by TEM in tumor tissue samples, we could 
try PCR-based detection of the universal 16S rRNA 
gene9,26 or immunefluorescence staining with 8D10.27 
Kajander and Ciftcioglu have discovered CNP in hu-
man and cow blood first1; then they developed their 
experiments by researching other mammalian cell 
cultures. They have shown the adherence of CNP to 
3T6 and other fibroblasts. CNP were bound as clus-
ters on the cell surfaces. Adherence took place on 
cellular extensions and to the perinuclear area of the 
cells. They thought CNP are internalized either by 
receptor-mediated endocytosis or by a closely related 
pathway.1,20 This important experiment have shown 
that, CNP have the ability to invade mammalian 
cells. Many mammalian malign cells have receptors 
for CNP adherence1 that could introduce CNP into 
the tumor with subsequent calcification.20 Guo et al 
9 speculated that the CNP detected in their placental 
tissue calcification was a novel type of nanoscale bac-
teria distinct from the nanobacteria isolated from kid-
ney stones and human blood, as reported elsewhere. 
They assumed that different nanobacteria may induce 
calcification by receptors in different human tissues, 
like nanobacteria receptor mediated tumor tissue cal-
cification. There might exist a special cell adhesion 
molecule in the outer membrane of the CNP to invade 
a cell. In the light of this research, the receptor-medi-
ated endocytosis pathway mechanism used by CNP 
may not be suitable for breast cells at all. 
In our study, the reason we could not observe CNP in 
the calcified breast tumor tissue may be a result of in-
sufficient calcified areas such that the amounts of cal-
cified areas were too small to isolate or they were lost 
in some steps. It is also said that calcification depends 
on the amount of calcifying nanoparticles present.9 
Moreover, it might be possible for us to see CNP in 
the calcified breast tumor tissue, if we could have a 
chance to culture more breast tumor tissues.
In this study, the presence of CNP in the breast tumor 
tissue was researched for the first time. Isolating and 
culturing CNP from breast tumor tissue has not been 
reported before. We think that this investigation will 
open a new area for researchers. Therefore, we won-
der if new culture parameters, tools and techniques 
can be used and developed in this new research area. 
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